APPENDIX IV

STATUTORY AND GENERAL INFORMATION

(b)

Senior Management

Our senior management (who is not a Director) have been granted options under the 2016 Share
Option and Incentive Plan which are outstanding to subscribe for a total of 9,717,810 Shares, and
approximately 1.27% of the issued share capital of our Company upon completion of the Global
Offering (assuming the Over-allotment Option is not exercised and no Shares are issued pursuant to
our Equity Plans).

Below is a list of the senior management (who are not Directors) who are grantees under the 2016

Share Option and Incentive Plan:

Name of
grantee

Role

Address

Exercise price

Number of
Shares under

the grant
outstanding

Date of grant

Option period

Approximate
percentage of
issued shares
immediately

after completion
of the Global
Offering(1)

Howard Liang .. Chief Financial

Officer and Chief
Strategy Officer

Amy Peterson ... Chief Medical

Officer,
Immuno-oncology

Jane Huang....... Chief Medical

Officer,
Hematology

Xiaobin Wu ..... General Manager,

China and
President

108 Lincoln Road,
Wayland, MA 01778
USA

6 Wellesley Drive,
Lafayette CA 94549
USA

3762 Jefferson Ave,
Redwood City CA
94062 USA

1248 B. Yosemite
No.4 Shunyi District
Beijing 100032
China

US$2.84
US$3.46
US$12.34
US$2.24
US$3.49
US$12.34
US$2.27
US$3.49
US$12.34
US$13.05

1,752,500
1,250,000

November 16, 2016
June 29, 2017
364,208 June 26, 2018

1,600,000
1,016,178

August 22, 2016
June 27, 2017
310,180 June 26, 2018

1,367,500
September 2, 2016
980,465
June 27, 2017
310,180 June 26, 2018
766,599 April 30, 2018

10 years from
date of grant

10 years from
date of grant

10 years from
date of grant

10 years from
date of grant

0.44%

0.38%

0.35%

0.10%

Note:

(1)

The above table assumes the Over-allotment Option is not exercised and no Shares are issued pursuant to our Equity

Plans.

(c) Other grantees

As of the Latest Practicable Date, other than the nine Directors and the four members of our
senior management (who are not Directors), no options were granted to any connected person of the
Company under the 2016 Share Option and Incentive Plan. Among these grantees, other than the nine
Directors and the four members of our senior management (who is not a Director), 711 grantees have
been granted options under the 2016 Share Option and Incentive Plan which are outstanding to
subscribe for a total of 69,812,744 Shares, representing approximately 9.10% of the issued share
capital of our Company upon completion of the Global Offering (assuming the Over-allotment Option
is not exercised and no Shares are issued pursuant to our Equity Plans) with the number of Shares to

— IV-20 —

